IQ

Data as of Nov 4, 2026.

vsOpen in the appCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Thematic ETFs

FMED vs XT: Holdings Overlap & Returns

Share
Share on XDownload as PDF

Over the year to Nov 4, 2026, FMED returned +27.4% to XT's +23.4%; 3% of their weight is in the same names.

askIQ about this page

askIQ about FMED and XT

Net assets: $52m on Sep 30, 2026 for Fidelity Disruptive Medicine ETF, and $4.0bn on Nov 4, 2026 for iShares Future Exponential Technologies ETF.

FMED on its own →XT on its own →
At a glance
21.8%
FMED in the S&P 500
65.0%
XT in the S&P 500
+27.4%
FMED total return, 1 year
+23.4%
XT total return, 1 year
FMED · 1 year to Nov 4, 2026 78% of its weight is outside the S&P 500
78% of its weight is outside the S&P 50022% of FMED's weight is in S&P 500 companies and 78% is outside the index. Holdings as of Aug 31, 2026.22%78%in the S&P 500of its weight outside the S&P 500active share 98% · top ten 33% of the fund · 72 holdings as filed for Aug 31, 2026 · Nasdaq-100: 5% in78% of its weight is outside the S&P 50022% of FMED's weight is in S&P 500 companies and 78% is outside the index. Holdings as of Aug 31, 2026.22%78%inoutside the S&P 500active share 98% · Nasdaq-100: 5% in

22% of FMED's weight is in S&P 500 companies and 78% is outside the index. Holdings as of Aug 31, 2026.

XT · 1 year to Nov 4, 2026 35% of its weight is outside the S&P 500
35% of its weight is outside the S&P 50065% of XT's weight is in S&P 500 companies and 35% is outside the index. Holdings as of Nov 3, 2026.65%35%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 70% · top ten 37% of the fund · 196 holdings as published by its issuer for Nov 3, 2026 · Nasdaq-100: 40% in35% of its weight is outside the S&P 50065% of XT's weight is in S&P 500 companies and 35% is outside the index. Holdings as of Nov 3, 2026.65%35%in the S&P 500outsideactive share 70% · Nasdaq-100: 40% in

65% of XT's weight is in S&P 500 companies and 35% is outside the index. Holdings as of Nov 3, 2026.

Pair scorecard

XT costs 0.04 points a year less; their one-year returns differ by 4.0 points.

Points (pts) are percentage points.

FMED vs XT: Holdings Overlap & Returns
MeasureFMEDXT
Return
Total return, 1 year+27.4%+23.4%
Against its benchmark
What it tracksBroad innovation and megatrendsBroad innovation and megatrends
Its benchmark, total return, 1 year+15.0%
Against its benchmark, 1 yearahead by 8.4 pts
Cost and size
Expense ratio0.50%0.46%
Net assets, FMED as of Sep 30, 2026 and XT as of Nov 4, 2026$52m$4.0bn
Holdings
Holdings in common3%
Top ten holdings, share of the fund33%36%

Method

What they share

3%

By the books each fund has filed, FMED and XT hold 3% of their money in the same securities at the same weight. Holdings dated Aug 31, 2026 and Nov 3, 2026.

0 half 100%

half

3% in common

Positions both hold · largest shared weight first FMED XT
INTUITIVE SURGICAL INC 2.05% 1.59%
DANAHER CORP 3.73% 0.75%
MODERNA INC 2.72% 0.38%
ILLUMINA INC 2.82% 0.17%
GUARDANT HEALTH INC 1.53% 0.11%
ALNYLAM PHARMACEUTICALS INC 2.33% 0.09%
REPLIGEN CORP 1.48% 0.05%
Only in one fund ↓
Only in FMED
10X GENOMICS INC 5.19%
THERMO FISHER SCIENTIFIC INC 3.83%
NATERA INC 3.30%
ARGENX SE 3.20%
LIFESTANCE HEALTH GROUP INC 3.00%
REVOLUTION MEDICINES INC 2.87%
HEARTFLOW INC 2.59%
SARTORIUS STEDIM BIOTECH 2.56%
Only in XT
ELI LILLY 4.83%
TEXAS INSTRUMENT 4.69%
TESLA INC 4.43%
MICROSOFT 4.10%
NVIDIA 3.53%
ANALOG DEVICES 3.34%
PALO ALTO NETWORKS 3.26%
JOHNSON & JOHNSON 3.04%
Check overlap with more funds →

Window by window

Window by window: FMED vs XT: Holdings Overlap & Returns
Total returnvs its benchmark
WindowFMEDXTFMEDXT
3 months+14.9%+2.8%not measured+4.1 pts vs ACWI
6 months+31.2%+7.5%not measured+4.9 pts vs ACWI
1 year+27.4%+23.4%not measured+8.4 pts vs ACWI
3 years+57.8%+78.5%not measured+0.9 pts vs ACWI
Since launchNot the same days: FMED Jun 2023 · XT Mar 2015+31.7%+293.9%not measured+69.3 pts vs ACWI

Open this comparison in the app →

Side by side

FMED Fidelity Disruptive Medicine ETF · Holds 72 stocks in broad innovation and megatrends, 22% of its weight in S&P 500 companies XT iShares Future Exponential Technologies ETF · Holds 196 stocks in broad innovation and megatrends, 65% of its weight in S&P 500 companies
Issuer Fidelity iShares
Theme Broad innovation and megatrends Broad innovation and megatrends
In the S&P 500 21.8% 65.0%
Active share vs the S&P 500 97.5% 69.8%
In the Nasdaq-100 5.1% 39.9%
Holdings 72 196
Top ten, share of the fund 33.2% 36.5%
Expense ratio 0.50% 0.46%
Fee for the differing part 0.51% 0.66%
Total return, 1 year +27.4% +23.4%
vs its benchmark not measured +8.4 pts vs ACWI
Below its high −0.9% −1.5%
Net assets, FMED as of Sep 30, 2026 and XT as of Nov 4, 2026 $52m $4.0bn

As of Nov 4, 2026. Source: ETFIQ.

3% of the two portfolios are the same securities at the same weight.

Alert

XT flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
FMED

By weight, 22% of FMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 33% of the fund across 72 positions, as filed for Aug 31, 2026. Over the year to Nov 4, 2026 the fund returned +27.4% with distributions reinvested.

XT

By weight, 65% of XT's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 70%. The top ten holdings are 36% of the fund across 196 positions, as published by its issuer for Nov 3, 2026. Over the year to Nov 4, 2026 the fund returned +23.4% with distributions reinvested against +15.0% for its benchmark, the MSCI All Country World Index, so a holder was ahead by 8.4 pts.

Questions people ask

Do FMED and XT hold the same stocks?
By their latest filings, 3% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, FMED or XT?
FMED has 22% of its weight in S&P 500 names and XT has 65%, so FMED differs more from the index.
Which is cheaper, FMED or XT?
FMED charges 0.50% a year and XT charges 0.46%, so XT is cheaper. Fees come from each fund's prospectus.
Other comparisons
FMED vs XDATFMED vs ARKKFMED vs QQQJFMED vs ILDRXT vs LENSXT vs HTECXT vs AOTGXT vs GDOC
Where to next
All thematic ETFs ranked by the S&P 500 Difference Score →How the scores are computed →FMED on its own →XT on its own →FMED dividend history →FMED holdings →XT dividend history →XT holdings →Method →Standards and sources →
Sources and dates
FMED filings on SEC EDGAR ↗
FMED prospectus with the expense ratio (SEC) ↗
Fidelity website ↗
XT filings on SEC EDGAR ↗
XT prospectus with the expense ratio (SEC) ↗
iShares page for XT ↗

Links are sources, not endorsements. A comparison is not a recommendation.

How this is computed

Overlap adds up the smaller of the two weights for each security both funds hold.

Every number is an ETFIQ calculation with distributions reinvested.

Cite this pageCitation, APA and Markdown

ETFIQ, FMED against XT, data as of Nov 4, 2026. https://etfiq.com/compare/themes/fmed-vs-xt

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.